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Introduction {#sec001}
============

In the vast world of mobile genetic elements, mobilizable genomic islands are increasingly recognized as key players in the global spread of multidrug resistance. To date, more than 30 islands mobilized in *trans* by helper conjugative plasmids have been described, most carrying drug or heavy metal resistance genes \[[@pgen.1008965.ref001]\]. One of the most atypical mobilizable genomic islands currently known is the 43-kb *Salmonella* Genomic Island 1 (SGI1) that was first described in 2000 in the multidrug-resistant epidemic strain of *Salmonella enterica* serovar Typhimurium DT104 \[[@pgen.1008965.ref002],[@pgen.1008965.ref003]\]. SGI1 is integrated in the 3' end of *trmE*, a gene coding for a GTPase involved in the modification of U34 in tRNA, and carries at its 3' end a complex class 1 integron named In104, which confers resistance to β-lactams, chloramphenicol, tetracycline, streptomycin, and sulfamethoxazole ([Fig 1A](#pgen.1008965.g001){ref-type="fig"}) \[[@pgen.1008965.ref003]\]. The discovery of dozens of SGI1 variants with a large variety of resistance profiles revealed the high plasticity of the class 1 integron \[[@pgen.1008965.ref004]\]. SGI1 and its variants have been described in a wide range of *S*. *enterica* serovars, in *Proteus mirabilis*, *Morganella morganii*, *Acinetobacter baumanii*, and more recently in avian pathogenic *Escherichia coli* \[[@pgen.1008965.ref005]--[@pgen.1008965.ref009]\]. The identification of SGI1 and variants in a broad range of species is suggestive of the high diffusion capacity of this mobile element.

![Monitoring of pVCR94 and SGI1 in cells by flow cytometry (FC).\
**A.** Schematic representation of chromosomally integrated SGI1. ORFs are represented by gray arrows. Gene numbers correspond to the last digits of locus tags S0xx in the Genbank accession number AF261825. ORFs of interest in this work are shown in brown. AcaCD binding sites are depicted by green angled arrows. Left (*attL*) and right (*attR*) junctions with the chromosome are indicated by black bars at the ends. The position of the complex class 1 integron In104 (multidrug resistance region) is indicated by a black arrowhead. **B.** Fluorescent reporter genes *mNeonGreen* (green arrow) and *mCherry* (red arrow) under the control of the *P*~*BAD*~ promoter were inserted in pVCR94 between *traG*~*C*~ and *eexC*, and in SGI1 between *S009* and *S010*. **C.** Representative flow cytometric scatter plots of green and red fluorescence of *E*. *coli* KH95 bearing either pVCR94^GreenKn^ or SGI1^RedKn^. **D.** Schematic representation of the labelled elements in the cells. SGI1^RedKn^ is integrated into the chromosome at the 3' end of *trmE*.](pgen.1008965.g001){#pgen.1008965.g001}

Although SGI1 is not self-transmissible, it is specifically mobilized by conjugative plasmids of the closely related IncA and IncC incompatibility groups \[[@pgen.1008965.ref010],[@pgen.1008965.ref011]\]. IncC plasmids are widespread in several pathogenic species of *Enterobacteriaceae* isolated from food products, food-producing animals and humans. IncC plasmids have been sporadically found in African seventh-pandemic isolates of *Vibrio cholerae* O1 El Tor, the causative agent of the diarrheal disease cholera \[[@pgen.1008965.ref012],[@pgen.1008965.ref013]\]. Nowadays IncC plasmids are globally distributed and considered to be important contributors to the diffusion of drug resistance genes, including New Delhi metallo-β-lactamase genes (*bla*~NDM~) that confer resistance against most β-lactams including carbapenems \[[@pgen.1008965.ref014],[@pgen.1008965.ref015]\]. Albeit not as epidemiologically successful, a highly conjugative IncA plasmid was recently found to participate in the emergence of carbapenemase-producing *Enterobacteriaceae* (*bla*~VIM-1~) that colonized the gut of patients in a university hospital in Italy \[[@pgen.1008965.ref016]\].

Several genes carried by SGI1 have been shown to be essential for its transfer. For instance, *int* and *xis* code for the integrase and recombination directionality factor that catalyze the integration of SGI1 into the 3' end of *trmE* and its excision from the chromosome ([Fig 1A](#pgen.1008965.g001){ref-type="fig"}) \[[@pgen.1008965.ref010]\]. Furthermore, the recently identified *mpsA* and *mpsB* code for key mobilization factors that recognize the upstream *cis*-acting origin of transfer loci (*oriT*) \[[@pgen.1008965.ref017]\]. Nevertheless, like all mobilizable genomic islands, SGI1 lacks a complete set of genes coding for a fully functional type IV secretion system (T4SS) to be self-transmissible and relies specifically on the T4SS encoded by IncA or IncC helper plasmids to transfer to a new host \[[@pgen.1008965.ref011]\]. However, unlike any other known mobilizable genomic island, SGI1 alters the mating apparatus encoded by IncC plasmids by replacing the T4SS proteins TraN~C~, TraG~C~, and TraH~C~ with its own distant orthologues TraN~S~, TraG~S~, and TraH~S,~ respectively \[[@pgen.1008965.ref018]\]. This remodeling not only seems to enhance SGI1 transfer at the expense of the helper plasmids but also disables entry exclusion mediated by IncA and IncC plasmids, thereby enabling the transmission of SGI1 to bacterial cells that bear such plasmids \[[@pgen.1008965.ref018],[@pgen.1008965.ref019]\]. Expression of *xis*, *traN*~*S*~ and *traHG*~*S*~ of SGI1 has been shown to be activated by the master activator complex AcaCD encoded by IncA and IncC plasmids \[[@pgen.1008965.ref018],[@pgen.1008965.ref020],[@pgen.1008965.ref021]\]. Therefore, excision of SGI1 from the chromosome occurs only in the presence of a helper plasmid. Together with the presence of the *sgiAT* toxin-antitoxin system, tight regulation of excision contributes to the high stability of SGI1 in the absence of an IncC plasmid \[[@pgen.1008965.ref022],[@pgen.1008965.ref023]\].

SGI1 and IncC plasmids are never found together in natural isolates \[[@pgen.1008965.ref024],[@pgen.1008965.ref025]\]. In fact, SGI1 was found to destabilize IncA and IncC plasmids after a few generations \[[@pgen.1008965.ref023],[@pgen.1008965.ref026]\]. Conversely, the presence of an IncC plasmid has been shown to enhance the recombination rate within SGI1, leading to the generation of SGI1 deletion variants \[[@pgen.1008965.ref022]\]. Conjugation-dependent rolling-circle replication of SGI1 has been suggested to be a possible explanation for this instability. Here, we characterize the cause of the apparent incompatibility between SGI1 and IncC plasmids using flow cytometry to monitor the segregation of the genomic island and its helper plasmid expressing different fluorescent proteins. While confirming the incompatibility, we observed an unexpected high-copy replication of the excised form of SGI1 that only occurred in the presence of the helper plasmid. Replication was confirmed by real-time quantitative PCR as well as DNA extraction and restriction of the replicative form. We identified an iteron-based origin of replication (*oriV*) downstream of a replication initiator gene whose expression is activated by an AcaCD-dependent promoter. Further investigations showed a clear link between incompatibility and SGI1 replication as replication-deficient mutants allowed stable cohabitation with the helper plasmid, even in the absence of any selection pressure.

Results {#sec002}
=======

Monitoring of SGI1 and pVCR94 incompatibility by flow cytometry {#sec003}
---------------------------------------------------------------

To monitor the fate of SGI1 and its helper IncC plasmid in cell populations by flow cytometry, we constructed SGI1^RedKn^ and pVCR94^GreenKn^ by inserting genes expressing red or green fluorescent reporter proteins between two converging genes to avoid interference with key functions ([Fig 1B](#pgen.1008965.g001){ref-type="fig"}). Flow cytometry monitoring of *E*. *coli* cells bearing either pVCR94^GreenKn^ or SGI1^RedKn^ revealed that \~97% and \~98% of the cells expressed the green and red fluorescent reporters under inducing conditions, respectively ([Fig 1C](#pgen.1008965.g001){ref-type="fig"}). These values were the maxima that could be reached for pure populations bearing either element. In this context, we used the green and red fluorescence as a proxy for the presence of the IncC plasmid and SGI1 in cells and assumed that pVCR94^GreenKn^ was present in a single copy per cell, and that a single copy of SGI1^RedKn^ was inserted at *trmE* per chromosome ([Fig 1D](#pgen.1008965.g001){ref-type="fig"}).

To measure by flow cytometry the previously reported incompatibility between SGI1 and IncC plasmids \[[@pgen.1008965.ref023],[@pgen.1008965.ref026]\], SGI1^RedKn^ and kanamycin-sensitive pVCR94^Green^ were introduced together by conjugation in *E*. *coli*, and the fluorescence of the resulting cell population was monitored over a 3-day period (\~54 generations) in the absence of antibiotics ([Fig 2A](#pgen.1008965.g002){ref-type="fig"}). While at the beginning of the assays (G0), 97.5% of the cells exhibited both green and red fluorescence, only 51% of the cells produced both signals after 18 generations (G18), and less than 0.5% after 54 generations (G54), thereby suggesting that SGI1 and pVCR94 are incompatible. To confirm that our observation resulted from plasmid or SGI1 loss, not from inactivating mutations in the reporter genes, antibiotics kanamycin and chloramphenicol were added at day 3. Selective pressure for both elements restored dual fluorescence in more than 97% of the cells, and the population of element-free cells nearly vanished ([Fig 2A](#pgen.1008965.g002){ref-type="fig"}, ATB).

![Incompatibility between SGI1 and IncC plasmids is trackable by FC.\
**A.** Evolution of the percentage of *E*. *coli* KH95 cells bearing SGI1^RedKn^ (SGI1) and pVCR94^Green^ (IncC) and grown over 54 generations in the absence of antibiotics as monitored using FC. Plots represent the mean and standard error of the mean obtained from three independent experiments. ATB is a recovery control culture at G54 in LB with selective pressure for both elements. **B.** Representative FC density plots of the data presented in panel A mapping the green signal (513 nm) as a function of the red signal (610 nm). **C.** Representative FC density plots of fluorescence intensity over forward scatter corresponding to data presented in panel B. Color keys are identical in all panels. In panel C, pink and red indicate cells producing low- and high-intensity red fluorescence, respectively.](pgen.1008965.g002){#pgen.1008965.g002}

Analysis of the individual scatter plots for the red and green channels revealed additional information regarding the incompatibility phenomenon. While the gradual loss of pVCR94^Green^ over time yielded two distinct cell populations (IncC^+^ and IncC^-^ cells) in the green channel, three distinct cell populations emerged in the red channel ([Fig 2C](#pgen.1008965.g002){ref-type="fig"}, bottom). At G18, \~57% of the cells exhibited high-intensity red fluorescence like 95% of the cells at G0. A second population emerged with a red fluorescent signal weaker than the initial population, but comparable to the intensity emitted by IncC plasmid-free cells bearing a single copy of SGI1^RedKn^ integrated at *trmE* ([Fig 1C](#pgen.1008965.g001){ref-type="fig"}, right). The presence of two cell subpopulations suggests a differentiation into two types of SGI1^+^ cells, one bearing a single integrated copy of SGI1^RedKn^ and the other bearing multiple copies. At G36 and G54, the subpopulation of cells with high-intensity red fluorescence collapsed, while the subpopulations with low or no red signal increased. The collapse of the high-intensity red fluorescent signal subpopulation correlated with the loss of green signal, i.e. the loss of pVCR94^Green^ ([Fig 2C](#pgen.1008965.g002){ref-type="fig"}, top), indicating that high-intensity red fluorescence was dependent on the presence of the IncC plasmid. Based on these observations, we hypothesized that in IncC^+^ cells, not only does SGI1 excise from the chromosome, but also undergoes a transient replication cycle that increases the production of mCherry protein in cells.

Active replication of SGI1 {#sec004}
--------------------------

To test whether SGI1 is able to replicate, we first prevented its excision from the chromosome by using a Δ*int* mutant of SGI1 that is unable to excise and remains permanently integrated in the chromosome \[[@pgen.1008965.ref010]\]. pVCR94^Green^ was then introduced into *E*. *coli* bearing SGI1^Red^ Δ*int* locked in *trmE*. We did not observe cells producing a high level of red fluorescence ([Fig 3A](#pgen.1008965.g003){ref-type="fig"}, compare WT and Δ*int*, and [S1A Fig](#pgen.1008965.s001){ref-type="supplementary-material"}), suggesting that SGI1 locked into the chromosome is unable to replicate, even in IncC^+^ cells.

![Replication of SGI1 in the presence of an IncC plasmid.\
**A.** Representative FC density plots of green and red fluorescence at G0 of cells bearing pVCR94^Green^ (IncC) and SGI1^Red^ (WT), its locked-in Δ*int* mutant and its Δ*rep* and Δ*oriV* mutants. **B.** Schematic representation of the cell content in the different mutants of panel A. **C.** Ethidium bromide-stained 0.8% agarose gel electrophoresis of EcoRI-digested plasmid DNA preparation of the same IncC^+^ cells bearing SGI1^Red^, its locked-in Δ*int* mutant or locked-out Δ*int* mutant (pSGI1). Lane 1, locked-in *trmE*::(SGI1^Red^ Δ*int*::*aph*); Lane 2, SGI1^Red^; Lane 3, pSGI1; Lane L, 2-Log DNA ladder. **D.** Effect of deletions on SGI1 copy number. Quantification by qPCR of the SGI1 copy number as measured by the *sgiA*/chromosome ratios at G0. **E.** Effect of deletions on SGI1 excision. Quantification by qPCR of the percentage of cells at G0 that contain excised SGI1 as a measure of unoccupied *attB* sites per 100 chromosomes. "x" indicates that excision was below the limit of detection (\<10^−5^%). Assays were carried out in *E*. *coli* KH95 carrying (+) or lacking (-) the helper IncC plasmid pVCR94^Green^ or pVCR94^GreenSp^ (for pSGI1 only). The bars represent the mean and standard error of the mean obtained from at least three independent experiments. Statistical analyses were carried out on the values using the one-way ANOVA with Tukey's multiple comparison test. **F.** Effect of SGI1 replication on conjugative transfer of SGI1 and its helper plasmid. Conjugation assays were carried out using *E*. *coli* KH95 as the donor and *E*. *coli* VB113 as the recipient. When indicated (+), Rep was provided in *trans* from p*rep*. Transfer frequencies are expressed as the number of transconjugant per donor CFUs. Statistical analyses were carried out on the logarithm of the values using the one-way ANOVA with Sidak's post-test to compare each mutant set relatively to SGI1^Red^ (WT) control. The bars represent the mean and standard deviation values obtained from at least three independent experiments. Statistical significance is indicated as follow: \*\*\*\*, *P*\<0.0001; \*\*\*, *P*\<0.001; \*, *P\<*0.05; ns, not significant.](pgen.1008965.g003){#pgen.1008965.g003}

To confirm SGI1 replication, we attempted to lock SGI1^Red^ Δ*int* out of the chromosome in a circular, replicative form that we called pSGI1. To do this, *int* was deleted while SGI1^Red^ was in its excised, circular state in cells that contained spectinomycin-resistant pVCR94^GreenSp^ with antibiotic selection to counter incompatibility. This can be achieved because the IncC plasmid stimulates SGI1 excision by activating the expression of *xis* through AcaCD \[[@pgen.1008965.ref020]\]. Plasmid DNA was extracted from cells carrying the resulting mutant and digested with EcoRI. A clear restriction pattern was expected only in conditions that would allow replication of a high number of SGI1 molecules. As expected, no restriction pattern was visible for the strain bearing chromosomally locked-in SGI1^Red^ Δ*int*, ([Fig 3C](#pgen.1008965.g003){ref-type="fig"}, lane 1). In contrast, EcoRI restriction patterns were easily detected for SGI1^Red^ or locked-out pSGI1 ([Fig 3C](#pgen.1008965.g003){ref-type="fig"}, lanes 2 and 3). Only high-copy number replication of SGI1 can explain our ability to extract, recover, and visualize plasmid DNA of the excised form of this genomic island.

To measure the variation of SGI1 copy number due to replication, we quantified SGI1 copy number per chromosome using real-time quantitative PCR (qPCR). In the IncC^+^ strain, SGI1^Red^ copy number increased 12-fold compared to the IncC^-^ strain and pSGI1 was maintained at \~6 copies per cell ([Fig 3D](#pgen.1008965.g003){ref-type="fig"}). Altogether, these results confirm that the subpopulation of cells that produced high-intensity red fluorescence in IncC^+^ cells corresponds to cells containing an excised replicative form of SGI1.

*rep* is required for SGI1 replication {#sec005}
--------------------------------------

Although its role in replication has never been demonstrated, the putative protein encoded by *S003*, also known as *rep*, contains a RepA_C domain (Pfam PF04796). The predicted translation product of *rep* shares 60% identity (78% similarity) with the putative replication initiator protein RepA encoded by plasmid pXAC64 of *Xanthomonas axonopodis* pv. *citri* \[[@pgen.1008965.ref027]\]. To determine whether *rep* plays a role in SGI1 replication, we constructed a *rep* deletion mutant of SGI1^Red^, and tested its ability to replicate in cells bearing pVCR94^Green^ using flow cytometry and qPCR to quantify its rate of excision and copy number. The data were compared with wild-type SGI1^Red^ and its Δ*traN*~*S*~ mutant as positive controls, and its Δ*int* and Δ*xis* mutants as negative controls. Excision of wild-type SGI1^Red^ was barely detectable in IncC^-^ cells (0.0000838%) whereas 81% of the cells contained excised SGI1^Red^ in IncC^+^ cells (\~7-log increase) ([Fig 3E](#pgen.1008965.g003){ref-type="fig"}). SGI1^Red^ and its Δ*traN*~*S*~ mutant behaved alike in IncC^+^ cells, with virtually all cells bearing the excised, replicative form (\>80% excision and \>10 copies per chromosome) ([Fig 3D and 3E](#pgen.1008965.g003){ref-type="fig"}). As expected, deletion of *int* or *xis* abolished excision, and led to a low copy number of SGI1^Red^ that was comparable to the wild-type in IncC^-^ cells. In contrast, while the Δ*rep* mutant retained the ability to excise from the chromosome (\>52% excision), it remained under 2 copies per cell ([Fig 3D and 3E](#pgen.1008965.g003){ref-type="fig"}), thereby supporting a key role of *rep* in SGI1 replication.

Flow cytometric data confirmed the inability of the Δ*int*, Δ*xis* and Δ*rep* mutants to replicate. Only low-intensity red fluorescence was detected despite the presence of the helper IncC plasmid, unlike the Δ*traN*~*S*~ mutant ([Fig 3A](#pgen.1008965.g003){ref-type="fig"}, and [S1A](#pgen.1008965.s001){ref-type="supplementary-material"}, [S2](#pgen.1008965.s002){ref-type="supplementary-material"}, [S3A](#pgen.1008965.s003){ref-type="supplementary-material"} and [S4A](#pgen.1008965.s004){ref-type="supplementary-material"} Figs). Complementation of Δ*int*, Δ*xis* and Δ*rep* mutations by expressing the corresponding gene under the control of the *P*~*BAD*~ promoter restored the high-intensity red fluorescence phenotype of the cells, indicating a restoration of SGI1 replication ([S1B](#pgen.1008965.s001){ref-type="supplementary-material"}, [S3B](#pgen.1008965.s003){ref-type="supplementary-material"} and [S4B](#pgen.1008965.s004){ref-type="supplementary-material"} Figs).

Identification of the origin of replication (*oriV*) of SGI1 {#sec006}
------------------------------------------------------------

Based on the presence of a *rep* gene and the inability of SGI1 Δ*rep* to replicate, we searched for nearby intergenic regions that could act as a potential *oriV* locus. Sequence analyses revealed a putative *oriV* immediately downstream of *rep* ([Fig 4A](#pgen.1008965.g004){ref-type="fig"}). This locus contains four GC-rich 17-bp direct repeats (iterons) and a putative DnaA box flanked by two AT-rich regions. The longest AT-rich region contains three direct and inverted copies of an imperfect 8-bp repeat ([Fig 4B](#pgen.1008965.g004){ref-type="fig"}). This configuration resembles the origin structure of typical iteron-containing replicons \[[@pgen.1008965.ref028]\]. To confirm that this putative *oriV* is essential for SGI1 replication, it was replaced with a Kn^R^ cassette without any alteration of the promoter region of *xis*. The resulting 255-bp deletion abolished SGI1^Red^ replication as shown by the lack of highly red fluorescent cells despite the presence of pVCR94^Green^ ([Fig 3A](#pgen.1008965.g003){ref-type="fig"}). Moreover, SGI1^Red^ Δ*oriV* retained the ability to excise at the same level as wild-type SGI1^Red^; however, its copy number per cell was considerably reduced and remained comparable to SGI1^Red^ in IncC^-^ cells or to its Δ*rep* mutant in IncC^+^ cells ([Fig 3D and 3E](#pgen.1008965.g003){ref-type="fig"}). Together, these results indicate that the sequence downstream of *rep* contains *oriV*.

![Identification of the *oriV* locus of SGI1.\
**A.** Schematic map of the *xis*-*S003* intergenic region of SGI1 containing *oriV*. **B.** Sequence of the *oriV* region of SGI1. Sequence features are indicated and color-coded as in panel A. The stem-loop of the putative rho-independent transcriptional terminator located downstream of *S003* has a calculated free energy (Δ*G*) of -8.9 kcal/mol (ARNold). **C**. Schematic representation of the *S004*-*rep* locus and translational *rep*'-'*lacZ* fusion. The translational *lacZ* fusion was introduced at position 3,246 after the fifth codon of *rep* (refer to [S6A Fig](#pgen.1008965.s006){ref-type="supplementary-material"} for details). The relative positions of reverse transcription primer rep_RT as well as PCR primers used to amplify *rep* and *S004* fragments are indicated. The dotted line shows reverse transcription product. **D**. *rep* expression is controlled by AcaCD. β-galactosidase assays of the translational *rep*'-'*lacZ* fusion in SGI1 Δ*xis* performed in IncC-free cells (-), and in the presence of pVCR94 or p*acaCD* without (no ara) or with arabinose (+ ara). **E**. Analysis on a 1.5% agarose gel from an assay to amplify *rep* and *S004* on the rep_RT cDNA. Genomic DNA (gDNA) and RNA samples in the absence of reverse transcriptase (noRT) were used, respectively, as positive and negative PCR controls.](pgen.1008965.g004){#pgen.1008965.g004}

Expression of SGI1 *rep* is activated by IncC plasmid encoded AcaCD {#sec007}
-------------------------------------------------------------------

To test the role of the IncC helper plasmid in SGI1 replication, the locked-out replicative form pSGI1 was subjected to the cohabitation test with pVCR94^GreenSp^ for 54 generations in the absence of selective pressure and analyzed by flow cytometry ([Fig 5A](#pgen.1008965.g005){ref-type="fig"} and [S5 Fig](#pgen.1008965.s005){ref-type="supplementary-material"}). As observed for SGI1^Red^, incompatibility led to the loss of both elements. However, while pVCR94^GreenSp^ persisted in 50% of the cells, pSGI1 was lost in virtually all cells after 54 generations. The other half of the cell population consisted of cells lacking both elements. This behavior is in stark contrast with SGI1^Red^ which was retained chromosomally integrated after 54 generations in more than 45% of the cells while the IncC plasmid was retained in less than 11% of the cells, with less than 0.5% of the cell population containing both elements ([Fig 2](#pgen.1008965.g002){ref-type="fig"}). Strict correlation of the plots of SGI1^+^ cells and SGI1^+^ IncC^+^ cells suggests that pSGI1 replication and stability are directly linked to the IncC plasmid. As pSGI1 did not integrate into the chromosome due to the missing *int* gene, we hypothesize that the IncC plasmid codes for an essential factor that sustains pSGI1 replication.

![Impact of SGI1 replication on incompatibility.\
Evolution of the percentage of *E*. *coli* KH95 cells bearing either pVCR94^GreenSp^ (IncC) and pSGI1 (A) or pVCR94^Green^ (IncC) and the Δ*traN*~*S*~ (B), Δ*int* (C), Δ*xis* (D), Δ*rep* (E), or Δ*oriV* (F) mutants of SGI1^Red^ (SGI1) over 54 generations in the absence of antibiotics as monitored by FC. Inserts for panels C, D and E show complementation experiments using the designated expression plasmid and pVCR94^GreenSp^. Conditions were identical to [Fig 2A](#pgen.1008965.g002){ref-type="fig"}. Plots represent the mean and standard error of the mean obtained from three independent experiments. Representative density plots of mNeongreen intensity over mCherry intensity and their corresponding plots of fluorescence intensity over forward scatter are shown for each condition in [S1](#pgen.1008965.s001){ref-type="supplementary-material"}--[S5](#pgen.1008965.s005){ref-type="supplementary-material"} and [S7](#pgen.1008965.s007){ref-type="supplementary-material"} Figs.](pgen.1008965.g005){#pgen.1008965.g005}

Our previous identification of an AcaCD binding site upstream of the *S004*-*rep* gene cluster suggests that *rep* could be expressed under the control of the IncC plasmid-encoded transcriptional activator AcaCD ([Fig 1](#pgen.1008965.g001){ref-type="fig"}) \[[@pgen.1008965.ref020]\]. To test this hypothesis, we first constructed a translational fusion between the fifth codon of *rep* and the eighth codon of *lacZ* in SGI1^Kn^ ([Fig 4C](#pgen.1008965.g004){ref-type="fig"} and [S6A Fig](#pgen.1008965.s006){ref-type="supplementary-material"}). This fusion also removes *xis* and *rep*, thereby preventing SGI1 excision and replication. β-galactosidase activity of the *rep*'-'*lacZ* fusion was then used as a proxy to measure the level of *rep* expression (transcription and translation) in the presence or absence of AcaCD. β-galactosidase activity was undetectable in IncC^-^ cells or in cells lacking p*acaCD* ([Fig 4D](#pgen.1008965.g004){ref-type="fig"}). In contrast, when AcaCD was provided by p*acaCD* with arabinose induction, we observed a 172±21-fold increase in β-galactosidase activity, and the presence of pVCR94^Sp^ resulted in a 11.9±0.3-fold increase compared to strain containing its Δ*acaCD* mutant. Comparable results were observed using a fusion that retained *xis*, allowing SGI1 excision but not its replication ([S6B and S6C Fig](#pgen.1008965.s006){ref-type="supplementary-material"}).

Furthermore, to confirm that *S004* and *rep* are part of the same mRNA transcript initiated at *P*~*S004*~, we conducted a PCR assay aimed at amplifying both genes from the same cDNA. To do this, RNA was extracted from cells bearing SGI1^Red^ alone, or in the presence of p*acaCD* with or without arabinose. *rep*-specific mRNA was reverse transcribed using a primer located at the 3' end of *rep* and used in a PCR assay to amplify fragments located within *S004* and *rep* ([Fig 4C](#pgen.1008965.g004){ref-type="fig"}). Our results confirmed that these two genes are cotranscribed and show unambiguously that *S004* and *rep* are part of the same operon that is activated by AcaCD ([Fig 4E](#pgen.1008965.g004){ref-type="fig"}).

SGI1 replication promotes instability of the IncC plasmid and inhibits cotransfer {#sec008}
---------------------------------------------------------------------------------

We observed that SGI1 replication and IncC instability are strongly correlated. SGI1 replication resulted in a strong incompatibility phenotype as shown by low counts of SGI1^+^ IncC^+^ cells that remained at G36 and G54 (Figs [2A](#pgen.1008965.g002){ref-type="fig"} and [5B](#pgen.1008965.g005){ref-type="fig"} and [S2 Fig](#pgen.1008965.s002){ref-type="supplementary-material"}). In contrast, mutants impaired for excision (Δ*int* and Δ*xis*) or replication (Δ*rep* and Δ*oriV*) exhibited a drastically reduced incompatibility as over 85% of the cells retained both SGI1 and the IncC plasmid at G54 ([Fig 5C--5F](#pgen.1008965.g005){ref-type="fig"}). Therefore, replication of SGI1 is responsible for the incompatibility phenotype observed with IncC plasmids.

Furthermore, when excision of SGI1 was abolished, we observed that retention of SGI1 was favored over pVCR94 (Δ*int*, 99.1% vs 87.5%, Δ*xis*, 99.6% vs 87.3%, respectively) ([Fig 5C and 5D](#pgen.1008965.g005){ref-type="fig"}, and [S1A](#pgen.1008965.s001){ref-type="supplementary-material"} and [S3A](#pgen.1008965.s003){ref-type="supplementary-material"} Figs). Conversely, retention of pVCR94 was favored when SGI1 was able to excise but unable to replicate (Δ*rep*, 97.6% vs 94.3%, Δ*oriV*, 92.6% vs 76.7%, respectively) ([Fig 5E and 5F](#pgen.1008965.g005){ref-type="fig"}, and [S4A](#pgen.1008965.s004){ref-type="supplementary-material"} and [S7A](#pgen.1008965.s007){ref-type="supplementary-material"} Figs). These observations suggest that replication plays a key role in the stability of SGI1 and improves its retention in cell populations colonized by IncC plasmids.

SGI1 and several of its variants were previously shown to inhibit cotransfer of IncC plasmids such as pRMH760 and pVCR94 \[[@pgen.1008965.ref020],[@pgen.1008965.ref026]\]. To test whether SGI1 replication could play a role in this inhibition, we carried out mating assays using the Δ*rep* and Δ*oriV* mutants of SGI1. These mating assays revealed that the frequency of cotransfer was comparable to the transfer of each single element ([Fig 3F](#pgen.1008965.g003){ref-type="fig"}), indicating that both mutations alleviated cotransfer inhibition. Furthermore, transfer of pVCR94 increased by 3 logs in both mutants suggesting that SGI1 replication strongly impairs the transfer of the IncC plasmids. We also observed that inhibition of cotransfer was restored as the frequency of cotransfer dropped below the detection limit when the Δ*rep* mutation was complemented by providing Rep from p*rep*. In this context, we observed a 27-fold reduction of pVCR94 transfer compared to the Δ*rep* mutant ([Fig 3C](#pgen.1008965.g003){ref-type="fig"}), while transfer of SGI1 increased 6-fold, thereby suggesting that replication provides a significant advantage to SGI1 compared to the IncC plasmid.

SGI1-like elements can encode an alternative replication initiator protein {#sec009}
--------------------------------------------------------------------------

A search for divergent SGI1 homologues sharing a genomic structure similar to SGI1 and GI-15 of *V*. *cholerae* O1 B33 (sulfamethoxazole and streptomycin resistance) revealed two SGI1-like elements with an alternative *rep* gene located at the same position as SGI1 *rep*. The first one, named GI*Vch*O27-1, was identified in the unique chromosome of *V*. *cholerae* O27 strain 10432--62, a strain isolated in the feces of a patient with diarrhea in 1962 in the Philippines \[[@pgen.1008965.ref029]\]. The second one, named GI*Sen*-26, was found in the genome of *S*. *enterica* serovar Muenster 26, a multidrug resistant strain isolated from horse feces at a Texan equine referral hospital. GI*Sen*-26 carries a class I integron (*aadA1*, *sul1*, *qacEΔ1*), a Tn*3*-like transposon (*strAB*, *tetA*), and a mercury resistance transposon (*merRTPFADE*). Both GIs are integrated at *trmE* and encode a replication protein unrelated to SGI1 and GI-15 Rep ([Fig 6](#pgen.1008965.g006){ref-type="fig"}). This alternative replication initiator protein contains an N-terminal replicase (PF03090) domain and an adjacent primase C terminal 1 (PriCT-1, PF08708) domain instead of the RepA_C domain. As expected in this context, SGI1 *oriV* is missing, and likely replaced by an alternative *oriV* that remains to be characterized.

![Comparison of the genetic maps of 4 SGI1-like genomic islands.\
Genomic islands are drawn to scale. The left and right junctions (*attL* and *attR*) within the host chromosome are indicated by black bars at the ends. ORFs with similar function are color coded as indicated in the figure. Green flags indicate the position and orientation of AcaCD binding sites predicted using MAST of the MEME suite \[[@pgen.1008965.ref030]\]. Homologous regions are bracketed and linked by a gray line with the corresponding percentage of nucleotide identity. Genbank accession numbers: SGI1, AF261825.2; GI-15, AAWE01000022); GI*Vch*O27-1, CP010812; GI*Sen*-26, QDTO01000013.](pgen.1008965.g006){#pgen.1008965.g006}

Furthermore, although the alternative *rep* gene is located upstream of an *S004* homologue, the putative translation product of this gene shares only 35% with S004, suggesting a functional replacement of the *oriV*-*rep*-*S004* fragment. However, as described in SGI1 and GI-15, the *S004* homologue is preceded by a predicted AcaCD-dependent promoter. BlastP analysis using the protein sequence of GI*Sen*-26 RepA revealed identical proteins (100% identity) encoded by SGI1-like elements in *S*. *enterica* (serovars Heidelberg, Typhimurium, Agona, Senftenberg, Infantis, Alachua, Cerro, Saint-Paul and Montevideo), *Rheinheimera nanhaiensis*, *V*. *cholerae*, *Vibrio mimicus*, *Shewanella algae*, *Shewanella fodinae*, *Escherichia albertii*, *E*. *coli* and *Proteus mirabilis*, including in the multidrug resistance-conferring PGI1-PEL of *P*. *mirabilis* PEL isolated in urine from a patient hospitalized in France (*aacA4*, *aadB*, *dhfrA1*, *qacEΔ1*, *sulI*, *bla*~*VEB-6*~, *aphA6*, *bla*~*NDM-1*~, *bleMBL*, *bla*~*DHA-1*~, *merRFPTADE*) \[[@pgen.1008965.ref031]\]. Therefore, although alternative replicons can be found in SGI1-like elements, autonomous replication appears to be an essential feature of the life cycle of SGI1-like GIs.

Discussion {#sec010}
==========

Mobile genetic elements such as conjugative plasmids and mobilizable genomic islands are potent drivers of antibiotic resistance gene dissemination. A better understanding of their lifecycle and interactions is essential to devise novel strategies aimed at curbing their propagation. In this study, we unraveled a yet unforeseen aspect of the complex interactions between IncC plasmids and SGI1, two types of mobile genetic elements that are both frequently found in several species of *Enterobacteriaceae* including *Salmonella enterica*, *Morganellaceae* and *Vibrionaceae* \[[@pgen.1008965.ref004],[@pgen.1008965.ref032]--[@pgen.1008965.ref034]\]. Previous reports of incompatibility between IncC (and IncA) plasmids and SGI1 emphasize the complexity of these interactions, especially when considering that SGI1 needs IncC or IncA plasmids to propagate \[[@pgen.1008965.ref020],[@pgen.1008965.ref023],[@pgen.1008965.ref026]\]. We undertook to investigate the underlying cause of incompatibility by labelling SGI1 and the helper IncC plasmid pVCR94 with fluorescent reporter genes to follow by flow cytometry their respective fates in a cell population. This strategy allowed us to confirm that SGI1 and IncC plasmids are incompatible as cells segregated into two subpopulations containing one or the other element after only a few generations. Furthermore, different cells contained different configurations of SGI1. Besides IncC plasmid-free cells that bear quiescent SGI1 integrated at *trmE*, we found that cells bearing an IncC plasmid contain SGI1 in an excised, high-copy replicative state. In IncC plasmid-free cells, virtually no excision of SGI1 was detected, whereas in IncC^+^ cells, up to 12 copies of SGI1 could be found in more than 80% of the cells. DNA of the replicative form of SGI1 (pSGI1) was easily extracted and profiled by EcoRI restriction, confirming the high copy number per cell.

We found that replication requires prior excision of SGI1 from the chromosome which occurs only in the presence of an IncA or IncC plasmid \[[@pgen.1008965.ref010],[@pgen.1008965.ref011]\]. Hence, replication of SGI1 mutants lacking *xis* or *int* could not be detected, even if initiation of replication of integrated SGI1 cannot be ruled out. Our analysis of SGI1 sequence revealed an iteron-based replicon with a *rep* gene coding for an uncharacterized replication initiator protein. *rep* is preceded by *S004*, a gene coding for a protein of unknown function that contains a predicted helix-turn-helix domain (HTH_17, Pfam PF12728). Murányi *et al*. \[[@pgen.1008965.ref035]\] presented evidence supporting an expression of *S004* driven from the AcaCD-responsive promoter *P*~*S004*~, while expression of the downstream gene *rep* (*S003*) would be very low and driven from a constitutive weak promoter located within *S004* regardless of AcaCD. Their analysis of *rep* expression relied on β-galactosidase assays with a transcriptional *lacZ* fusion that substituted *lacZ* for *rep* at the start codon in a multi-copy reporter plasmid containing most of *S004* and its promoter region (position 3,261--3,639 of SGI1) seemingly displacing *S004* stop codon. In contrast, we devised a translational *rep*'-'*lacZ* fusion constructed in SGI1. In this more natural context, our results show that *S004*-*rep* is an operon driven from *P*~*S004*~, directly under the control of AcaCD. Hence excision and replication of SGI1 are coordinated events controlled by the same transcriptional activator produced by IncA and IncC plasmids. Consistent with this observation, we found that replication of pSGI1, the locked-out form of SGI1 Δ*int*, cannot persist in the absence of the helper IncC plasmid. Furthermore, consistent with AcaCD-induced expression of *rep*, destabilization of the IncC plasmid triggered by pSGI1, ultimately resulted in the concomitant loss of pSGI1 ([Fig 5A](#pgen.1008965.g005){ref-type="fig"}).

We also found that although *S004*-*rep* expression was off in IncC^-^ cells, the operon was weakly expressed in the presence of a Δ*acaCD* mutant of the helper plasmid ([Fig 4D](#pgen.1008965.g004){ref-type="fig"}). This observation suggests that another IncC plasmid-encoded factor triggers *rep* expression, directly or indirectly, perhaps through the activation of *sgaCD* (aka *flhDC*~*SGI1*~) expression. *sgaCD* is carried by SGI1 and encodes a close homologue of AcaCD (89% and 67% identity for the C and D subunits, respectively) \[[@pgen.1008965.ref021],[@pgen.1008965.ref035],[@pgen.1008965.ref036]\]. SgaCD has been shown to activate AcaCD-dependent promoters of SGI1, though at a lower level than AcaCD \[[@pgen.1008965.ref035]\]. While the exact role of SgaCD in SGI1 biology is currently unknown, a natural variant of SGI1 that lacks *sgaCD*, SGI1-K, has been shown to be unable to destabilize the IncC plasmid pRMH760 \[[@pgen.1008965.ref026]\], suggesting a possible link between SgaCD, SGI1 replication and IncC plasmid destabilization. Identification of the IncC plasmid-encoded factor and pathway that control *rep* expression in the absence of *acaCD* is ongoing.

Little is known about SGI1's replicon as the product of *rep* has not been characterized. To the best of our knowledge, the closest relative of SGI1 Rep is RepA of plasmid pXAC64 of *X*. *axonopodis* pv. *citri* that was identified by sequencing only and not studied further \[[@pgen.1008965.ref027]\]. Therefore, additional studies are needed to better understand the molecular mechanism by which SGI1 replicates, the control mechanisms that affect the copy number of its excised form as well as the mechanism, whether direct or indirect, by which it affects the stability of IncC plasmids. We showed that suppression of SGI1 excision and/or replication functions (*xis*, *int*, *rep*, *oriV*) enables stable coexistence of SGI1 and its helper plasmid. Surprisingly, overexpression of *rep* in complementation assays led to a destabilization of SGI1 over the IncC plasmid ([Fig 5E](#pgen.1008965.g005){ref-type="fig"}). High intracellular Rep concentration could inhibit replication through "handcuffing", a mechanism that couples replication origins via iteron-bound Rep proteins, turning off origin function as reported for the *π* replicase of plasmid R6K \[[@pgen.1008965.ref037]\]. Replication of iteron-based plasmids involves the recruitment of the chromosomal replication initiator protein DnaA. We identified in the *oriV* of SGI1 a putative DnaA box and four 17-bp iterons (consensus RKGGGGGHRATTATGCG) ([Fig 4A](#pgen.1008965.g004){ref-type="fig"}). IncA and IncC replicons also contain a single DnaA box and 11 to 14 copies of 19-bp iterons that differ in sequence (yaTRTGGGDNHgcTGCACG and yaTRTGGGNNcgcTGCACG, respectively) with SGI1 iterons \[[@pgen.1008965.ref038],[@pgen.1008965.ref039]\]. Destabilization of IncA and IncC plasmids by SGI1 replication could result from the titration of host-encoded replication proteins by the *oriV* of replicating SGI1. DnaA titration by the DnaA box of multicopy SGI1 could be a mechanism preventing proper initiation of IncA and IncC plasmid replication. Alternatively, SGI1 could produce a protein that interferes with key maintenance functions that are conserved in IncA and IncC plasmids such as replication (*repA*), partition (*parAB*, *053*) or post-segregational killing (*tad*-*ata*) \[[@pgen.1008965.ref020],[@pgen.1008965.ref040]\]. This factor would be produced when SGI1 is excised and replicating, and not produced or produced in insufficient quantity when in single copy in the cell, that is in cells devoid of helper plasmid.

Integrative and conjugative elements (ICEs), such as ICE*Bs1* of *Bacillus subtilis*, ICE*St3* of *Streptococcus thermophilus*, Tn*916* of *Enterococcus faecalis*, R391 of *Providencia rettgeri* or ICE*clc* of *Pseudomonas putida*, were shown to undergo transient replication after excision from the chromosome \[[@pgen.1008965.ref041]--[@pgen.1008965.ref045]\]. For these mobile elements, increased copy number results from an intercellular rolling-circle replication mechanism initiated at the *oriT* locus by the conjugative relaxase that is used as a replication initiator protein. In contrast, we found that replication of SGI1 relies on a dedicated *rep* gene and *oriV* that are distinct from the *oriT* and *mpsAB* mobilization genes \[[@pgen.1008965.ref017]\]. In this respect, SGI1 resembles integrative and conjugative elements found in Actinomycetes such as *Streptomyces* pSAM2 \[[@pgen.1008965.ref046]\]. These self-transmissible elements rely on a single FtsK/SpoIIIE-like protein channel that translocates double-stranded molecules into adjacent cells within the hyphae of these filamentous bacteria. Hence to prevent loss in the donor cell, they replicate using a dedicated *oriV* and rolling-circle replication initiator proteins, such as RepSA, RepAM or Rep2, that seem to be expressed only after excision from their host chromosome \[[@pgen.1008965.ref047],[@pgen.1008965.ref048]\]. *Staphylococcus aureus* pathogenicity islands (SaPIs) and recently discovered phage-inducible chromosomal islands (PICIs) in *Enterobacteriaceae* and *Pasteurellaceae* are phage satellites that parasite temperate helper bacteriophages for their own dissemination \[[@pgen.1008965.ref049]\]. Like SGI1, SaPIs and PICIs excise from the chromosome of their host and undergo active replication in the presence of their helper element. Their replication, which is usually mediated by a primase and replicase that they encode, is necessary to allow packaging of the phage satellite genome into viral particles. Whereas in all these instances, the biological role of replication is clear, the function ensured by SGI1 replication remains uncertain. The need for a dedicated replicon on SGI1 for the sole purpose of retaining a copy of SGI1 in donor cells after conjugative transfer seems to be overkill as this function is expected to be ensured by the template strand during intracellular rolling-replication initiated at *oriT*, unless SGI1 lacks a functional single-strand origin (*sso*) that could be required to resynthesize the transferred strand from the template strand as shown for Tn*916* or ICE*Bs1* \[[@pgen.1008965.ref043],[@pgen.1008965.ref050]\]. Nevertheless, the discovery of SGI1-like elements with alternative *rep* genes ([Fig 6](#pgen.1008965.g006){ref-type="fig"}) suggests an important role of replication in the life cycle of genomic islands of the SGI1 family at large.

Unambiguously, replication of SGI1 has a destabilizing effect on IncC plasmid maintenance. In addition, replication functions seem to play a role in the reduction of cotransfer of SGI1 and its helper plasmid, which in return could help stabilize SGI1 in its new host by preventing futile excision and eventual loss. Furthermore, as shown previously, SGI1 reshapes the mating pore encoded by the IncC plasmid to promote its self-propagation. SGI1 encodes alternative TraN, TraG, and TraH subunits, which results in the replacement of the cognate subunits encoded by the IncC plasmid in the mating pore \[[@pgen.1008965.ref018]\]. This substitution was shown to enhance the transmissibility of SGI1. High SG1 copy number could increase the production of TraN~S~, TraG~S~, and TraH~S~, facilitating the alteration of the mating pore to enhance SGI1 propagation at the expense of the helper plasmid. Consistent with this hypothesis, deletion of *rep* or *oriV* suppressed the inhibition of IncC plasmid transfer phenotype ([Fig 3F](#pgen.1008965.g003){ref-type="fig"}).

SGI1 replication is linked to its incompatibility with IncC plasmids, and one may wonder what evolutionary benefit SGI1 can get from destabilizing its helper element. IncC plasmids mobilize other genomic islands, such as the multidrug resistance island MGI*Vch*Hai6 found in clinical non-O1/non-O139 *V. cholerae* isolates \[[@pgen.1008965.ref020],[@pgen.1008965.ref051]--[@pgen.1008965.ref053]\]. Yet, unlike SGI1, MGI*Vch*Hai6 lacks a *rep* homologue and transfers at a much lower rate \[[@pgen.1008965.ref051]\]. Furthermore, MGI*Vch*Hai6 is not as prevalent in Gammaproteobacteria. One reason could be that by allowing the co-residence of its helper plasmid in the cell, MGI*Vch*Hai6 is subjected to a high rate of excision that undermines its stability during cell division. On the contrary, SGI1 prevents long-term co-residence of its helper plasmid, as it has been shown to inhibit co-transfer and promote plasmid loss \[[@pgen.1008965.ref026]\]. A key element of SGI1 epidemiological success could be the association between replication and entry exclusion evasion. SGI1 evades entry exclusion of IncC plasmids, allowing its transfer to recipient cells containing an IncC plasmid \[[@pgen.1008965.ref018],[@pgen.1008965.ref019]\]. Upon entry into such cells, SGI1 cannot stably integrate into the chromosome. Instead, SGI1 actively replicates which could favor its epidemic spread into neighboring IncC^+^ cells, thanks to entry exclusion evasion. Ultimately, by triggering population-wide helper plasmid loss, SGI1 prevents *xis* and *rep* expression due to AcaCD depletion, thereby promoting its stabilization through integration into the host chromosome.

SGI1 and its siblings seem to have evolved a fiery love/hate relationship with their helper plasmids, relying exclusively on them to disseminate while preventing their cotransfer and mid- and long-term coexistence within the same cell. Based on our results, SGI1 replication likely plays an important role in this complex interaction. Even so, how exactly replication affects plasmid stability remains to be unraveled. One key aspect to investigate is the influence of copy number shift and how it affects gene expression and production of SGI1-specific proteins that may interfere with the replication, partition in daughter cells and transfer of IncA and IncC plasmids.

Materials and methods {#sec011}
=====================

Strains, media and antibiotics {#sec012}
------------------------------

The strains used in this study are listed in [Table 1](#pgen.1008965.t001){ref-type="table"}. The strains were routinely grown in lysogeny broth (LB-Miller, EMD) at 37°C in an orbital shaker/incubator and were preserved at -80°C in LB broth containing 30% (vol/vol) glycerol. Antibiotics were used at the following concentrations: ampicillin (Ap), 100 μg/ml; chloramphenicol (Cm), 20 μg/ml; kanamycin (Kn), 50 μg/ml; nalidixic acid (Nx), 40 μg/ml; rifampicin (Rf), 50 μg/ml; spectinomycin (Sp), 50 μg/ml; tetracycline (Tc), 12 μg/ml. When required, bacterial cultures were supplemented with 0.02% L-arabinose.

10.1371/journal.pgen.1008965.t001

###### *E*. *coli* K-12 derivative strains, plasmids and genomic islands used in this study.

![](pgen.1008965.t001){#pgen.1008965.t001g}

  Strain, plasmid or genomic island   Relevant genotype or phenotype[^*a*^](#t001fn001){ref-type="table-fn"}                             Source or reference
  ----------------------------------- -------------------------------------------------------------------------------------------------- ----------------------------
  *Strains*                                                                                                                              
      BW25113                         F^-^ Δ(*araD-araB*)*567*, Δ*lacZ4787*(::*rrnB-3*), λ^-^, *rph-1*, Δ(*rhaD-rhaB*)*568*, *hsdR514*   \[[@pgen.1008965.ref054]\]
      KH95                            BW25113 *rpoB526* (Rf)                                                                             This study
      VB113                           Nx-derivative of BW25113 (Nx)                                                                      \[[@pgen.1008965.ref055]\]
  *Plasmids*                                                                                                                             
      pKD3                            PCR template for one-step chromosomal gene inactivation (Cm)                                       \[[@pgen.1008965.ref054]\]
      pKD4                            PCR template for one-step chromosomal gene inactivation (Kn)                                       \[[@pgen.1008965.ref054]\]
      pVI42B                          pVI36 BamHI::*P*~*lac*~-*lacZ*                                                                     \[[@pgen.1008965.ref056]\]
      pMFflT-o4-neonGreen             PCR template for *mNeonGreen* amplification (Tc)                                                   S. Rodrigue
      pMS1                            pSC101 *cI857*; *P*~*L*~-*gam*-*bet*-*exo*; *gen*; λRed expression vector (Ts, Gm)                 \[[@pgen.1008965.ref055]\]
      pBAD30                          *ori*~p15A~ *araC P*~*BAD*~ (Ap)                                                                   \[[@pgen.1008965.ref057]\]
      pVCR94                          IncC conjugative plasmid (Su Tm Cm Ap Tc Sm)                                                       \[[@pgen.1008965.ref055]\]
      pVCR94^Sp^                      Sp^R^ derivative of pVCR94 (Sp Su)                                                                 \[[@pgen.1008965.ref019]\]
      pVCR94^GreenSp^                 pVCR94^Sp^ *traG*~*c*~Ω(*P*~*BAD*~-*mNeonGreen*-FRT) (Sp Su)                                       This study
      pVCR94^GreenKn^                 pVCR94 *traG*~*c*~Ω(*P*~*BAD*~-*mNeonGreen*-FRT-*aph*-FRT) (Kn Su Tm Cm Ap Tc Sm)                  This study
      pVCR94^Green^                   pVCR94 *traG*~*c*~Ω(*P*~*BAD*~-*mNeonGreen*-FRT) (Su Tm Cm Ap Tc Sm)                               This study
      pRed                            pBAD30::*mCherry* (Ap)                                                                             This study
      pGreen                          pBAD30::*mNeonGreen* (Ap)                                                                          This study
      pRedKnFRT                       pRed::FRT-*aph*-FRT (Ap Kn)                                                                        This study
      pGreenKnFRT                     pGreen::FRT-*aph*-FRT (Ap Kn)                                                                      This study
      p*acaCD*                        pBAD30::*acaCD*                                                                                    \[[@pgen.1008965.ref020]\]
      p*int*                          pBAD30::*int* (*S001*)                                                                             This study
      p*xis*                          pBAD30::*xis* (*S002*)                                                                             This study
      p*rep*                          pBAD30::*rep* (*S003*)                                                                             This study
      pSGI1                           SGI1^Red^ Δ*int*::*aph* (Cm Kn) resulting from post-excision *int* deletion                        This study
  *Genomic islands*                                                                                                                      
      SGI1                            SGI1 inserted at the 3' end of *trmE* (Ap Cm Sp Sm Su Tc)                                          \[[@pgen.1008965.ref003]\]
      SGI1^Kn^                        ΔIn104::*aph* mutant of SGI1 devoid of the integron In104 (Kn)                                     \[[@pgen.1008965.ref018]\]
      SGI1^Cm^                        ΔIn104::*cat* mutant of SGI1 devoid of the integron In104 (Cm)                                     This study
      SGI1^RedKn^                     SGI1^Cm^ *S009*Ω(*P*~*BAD*~-*mCherry*-FRT-*aph*-FRT) (Cm Kn)                                       This study
      SGI1^Red^                       SGI1^Cm^ *S009*Ω(*P*~*BAD*~-*mCherry*-FRT) (Cm)                                                    This study
      SGI1^Red^ Δ*int*                Δ*S001*::*aph* mutant of SGI1^Red^ (Cm Kn)                                                         This study
      SGI1^Red^ Δ*xis*                Δ*S002*::*aph* mutant of SGI1^Red^ (Cm Kn)                                                         This study
      SGI1^Red^ Δ*rep*                Δ*S003*::*aph* mutant of SGI1^Red^ (Cm Kn)                                                         This study
      SGI1^Red^ Δo*riV*               Δ*oriV*::*aph* mutant of SGI1^Red^ (Cm Kn)                                                         This study

^*a*^ Ap, ampicillin; Cm, chloramphenicol; Gm, gentamycin; Kn, kanamycin; Nx, nalidixic acid; Rf, rifampicin; Sp, spectinomycin; Sm, streptomycin; Su, sulfamethoxazole; Tc, tetracycline; Tm, trimethoprim; Ts, thermosensitive.

Molecular biology methods {#sec013}
-------------------------

Genomic and plasmid DNA were prepared using the QIAmp DNA Mini Kit (Qiagen) and EZ-10 Spin Column Plasmid DNA Minipreps Kit (Biobasic), respectively, according to the manufacturer's instructions. Oligonucleotide primers were purchased from Integrated DNA Technologies. When necessary, PCR products were purified using the QIAquick PCR Purification Kit (Qiagen) according to the manufacturer's instructions. Ligations were performed using T4 DNA ligase (New England Biolabs) with cloning vectors that were dephosphorylated using Antarctic Phosphatase (New England Biolabs) according to the manufacturer's instructions. *E*. *coli* was transformed by electroporation according to Dower *et al*. \[[@pgen.1008965.ref058]\]. Electroporation was carried out in a BioRad GenePulser Xcell apparatus set at 25 μF, 200 V and 1.8 kV using 1-mm gap electroporation cuvettes. Sequencing reactions were performed by the Plateforme de Séquençage et de Génotypage du Centre de Recherche du CHUL (Québec, QC, Canada).

Plasmid constructions {#sec014}
---------------------

Plasmids and primers used in this study are described in [Table 1](#pgen.1008965.t001){ref-type="table"} and [S1 Table](#pgen.1008965.s008){ref-type="supplementary-material"}, respectively. PCR fragments were amplified using Q5 High-Fidelity DNA Polymerase (New England BioLabs). *mCherry* and *mNeonGreen* were respectively amplified using primer pairs Fw-EcoRI-RBSMC/Rv-MC-KpnI and Fw-EcoRI-RBSNG/Rv-NG-KpnI from plasmids pmCherry (Takara) and pMFflT-o4-neonGreen, respectively. These PCR fragments were digested with EcoRI and KpnI, and cloned into pBAD30 digested with the same enzymes, yielding pRed and pGreen with the reporter genes under the control of the *P*~*BAD*~ promoter. To construct pRedKnFRT and pGreenKnFRT, pKD4 was digested by HindIII and PvuI to recover the 1,645-bp HindIII fragment (Flp recombination target (FRT)-flanked *aph* resistance gene cassette (Kn^R^)) that was subsequently cloned into pRed and pGreen cut with HindIII. To construct the expression vectors p*int*, p*xis* and p*rep*, PCR fragments containing *int*, *xis* or *rep* were amplified from genomic DNA of *E*. *coli* MG1655 bearing SGI1 as the template and primer pairs SGI1intEcoRI.for/SGI1intEcoRI.rev, SGI1xisEcoRIb.for/SGI1xisEcoRI.rev, and Fw-KpnI-Rep/Rv-Rep-SalI, respectively. The PCR fragments were digested by EcoRI, or KpnI and SalI and cloned into pBAD30 cut with the same enzymes. The integrity of all resulting plasmids was confirmed by restriction profiling and DNA sequencing.

Construction of insertion and deletion mutants {#sec015}
----------------------------------------------

All insertion and deletion mutants in pVCR94 and SGI1 were constructed in *E*. *coli* BW25113 using the one-step chromosomal gene inactivation technique \[[@pgen.1008965.ref054]\]. The λRed recombination system was expressed using pMS1 as described by Datta *et al*. \[[@pgen.1008965.ref059]\]. All mutations were designed to be non-polar. SGI1^Cm^, a Cm-resistant derivative of SGI1 devoid of In104 was obtained using primer pair SGI1In104cm2.f/SGI1In104cm2.r and pKD3 as the template. SGI1^RedKn^ was constructed by introducing *araC*-*P*~*BAD*~::*mCherry*-FRT-*aph*-FRT into the intergenic region between *S009* and *S010* in SGI1^Cm^ using primer pair FwpBADInsMCSGI1/RvpBADInsMCSGI1 and pRedKnFRT as the template. pVCR94^GreenKn^ and pVCR94^GreenSp^ were constructed by introducing *araC*-*P*~*BAD*~::*mNeonGreen*-FRT-*aph*-FRT between *traG* and *eexC* in pVCR94 and pVCR94^Sp^ using primer pair FwpBADInsNGpVCR/RvpBADInsNGpVCR, and pGreenKnFRT as the template. The FRT-flanked Kn^R^ cassette was removed by Flp-catalyzed excision using pCP20 \[[@pgen.1008965.ref054]\] to generate SGI1^Red^ and pVCR94^Green^. Deletion of *int*, *xis*, *rep*, *traN*~*S*~ and *oriV* in SGI1^Red^ was carried out using the same technique with primer pairs SGI1delint.for/SGI1delint.rev, SGI1delxis.for/ SGI1delxis.rev, SGI1deIRep.for/SGI1deIRep.rev, SGI1dels005.for/SGI1dels005.rev, and Fw-DelOriRSGI1/Rv-DelOriRSGI1, respectively, and pKD4 as the template. The translational fusions Δ(*xis*-*oriV*)-*rep*'-'*lacZ* and *rep*'-'*lacZ* in SGI1^Kn^ were constructed using primer pairs rep-lacZ.f/rep-lacZdelxis.r2 and rep-lacZ.f/rep-lacZ.r2, and pVI42B as the template. Scars in all constructions were determined by PCR and Sanger sequencing.

Cohabitation assays {#sec016}
-------------------

All cohabitation experiments were done as follows. The strains containing both elements were inoculated in LB broth with selective pressure (Kn for SGI1^RedKn^ or SGI1^Red^ deletion mutants, and Tc for pVCR94^Green^) and arabinose for induction of the reporter genes, and grown overnight at 37°C. On the next day, the cultures were used to inoculate (1:2,000 dilution) fresh LB broth with arabinose without antibiotics and incubated at 37°C. Furthermore, the overnight grown culture (stationary phase cells) was diluted 1:1,000 in PBS and analyzed by flow cytometry. This quantification was defined as the initial population composition (G0). This population was considered as pure and suitable for the experiment if more than 95% of the cells were positive for green and red fluorescence. Subsequently, cultures were passaged twice a day in fresh medium, which equals approximately 9 generations per passage. Flow cytometry analyses were done on stationary phase cells at days 1, 2 and 3, corresponding approximately to generations 18, 36 and 54. At the end of the experiment, the last passage was performed with selective pressure to restore the initial population. This control confirmed that loss of fluorescence resulted from element instability, not from mutations in the reporter genes.

For mutant complementation assays, the same conditions were used except that pVCR94^Green^ was replaced with pVCR94^GreenSp^ due the Ap^R^ phenotype conferred by both pVCR94^Green^ and pBAD30.

Flow cytometry {#sec017}
--------------

Culture samples were diluted 1:1,000 in 500 μl of PBS. Fluorescence intensity of NeonGreen and mCherry in cells was monitored by flow cytometry analysis on a BD FACSJazz (BD Biosciences), and data were acquired with the BD FACS Sortware. mNeonGreen and mCherry were excited with 488 and 561 nm solid-state lasers, and their emission was detected using 513/17 and 610/20 nm emission filters, respectively. For each sample, fluorescence of 20,000 cells was captured, and the data was analyzed using FCS Express 7 (De Novo Software).

RNA extraction and cDNA synthesis {#sec018}
---------------------------------

Briefly, RNA extractions were performed as follows. *E*. *coli* KH95 containing SGI1^Red^ with or without p*acaCD* was grown at 37°C for 16 h in LB broth containing the appropriate antibiotics. The cultures were diluted 1:100 in fresh medium containing the appropriate antibiotics and grown to an OD~600~ of 0.2 before being diluted 1:10 again in fresh medium containing the appropriate antibiotics and supplemented with 0.02% arabinose when needed. After a 2h incubation period, 1 ml of the culture was used for total RNA extraction using Direct-zol RNA extraction kit (Zymo Research) and TRI Reagent (Sigma-Aldrich) according to the manufacturer's instructions. Once purified, the RNA samples were treated using 2 units of DNase I (New England Biolabs) according to the manufacturer's instructions to eliminate any residual gDNA. cDNA was synthesized from 0.2 μg of RNA and 2 pmol of gene-specific primer rep_RT (Integrated DNA Technologies), using the reverse transcriptase SuperScript III (Invitrogen), according to the manufacturer's instructions. Control reactions without reverse transcriptase treatment ('noRT') were performed for each sample. PCR reactions aiming at amplifying *rep*, *S004* and *traN*~*S*~ were carried out using cDNAs as described in Garriss *et al*. \[[@pgen.1008965.ref060]\].

β-galactosidase assays {#sec019}
----------------------

Qualitative assays were performed by depositing 10μl aliquots of overnight cultures with appropriate antibiotics on solid agar supplemented with 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) with or without 0.02% arabinose. The plates were observed after an overnight incubation at 37°C. Quantitative assays were performed with 2-nitrophenyl-β-D-galactopyranoside (ONPG) according to a protocol adapted from Miller \[[@pgen.1008965.ref061]\]. After an overnight incubation at 37°C with appropriate antibiotics with or without 0.2% arabinose, cultures were diluted 1:100 in 50ml LB broth with appropriate antibiotics with or without 0.2% arabinose and grown until an OD~600~ of 0.2 was reached. Two series of 1:10 dilutions were then prepared in total volumes of 5ml LB broth supplemented with appropriate antibiotics with or without 0.2% arabinose and incubated for 2 hours at 37°C. Values are expressed as the mean and standard error of the mean values calculated from three biological replicates.

qPCR {#sec020}
----

Quantification of the copy number of pVCR94 as well as excision rate and copy number of SGI1 forms (circular or integrated) were assessed by real-time quantitative qPCR. Primers used in this quantification are listed in [S1 Table](#pgen.1008965.s008){ref-type="supplementary-material"}. The data were analyzed using the threshold cycle (ΔΔ*C*~*T*~) method using the three target genes *dnaB*, *hicB* and *trmE* as chromosomal references. Copy number of pVCR94 and SGI1 was assessed using *repA* and *sgiA* as the targets, respectively. Excision of SGI1 was assessed using the chromosomal free *attB* site as the target. qPCR experiments were performed in triplicate on the RNomics Platform of the Laboratoire de génomique fonctionnelle de l'Université de Sherbrooke ([https://rnomics.med.usherbrooke.ca](https://rnomics.med.usherbrooke.ca/)) (Sherbrooke, QC, Canada).

Identification of *oriV* {#sec021}
------------------------

Search for direct and inverted sequence repeats in the region downstream of *S003* was carried out using the genomic similarity search tool Yass \[[@pgen.1008965.ref062]\] available at <https://bioinfo.lifl.fr/yass/index.php> and the MEME motif discovery algorithm \[[@pgen.1008965.ref030]\] available at <http://meme-suite.org/index.html>. Identification of putative DnaA boxes was carried out using MAST \[[@pgen.1008965.ref063]\] with the DnaA motif matrix (accession MX000098) obtained from PRODORIC Release 8.9. Prediction of Rho-independent transcription terminator was carried out using ARNold \[[@pgen.1008965.ref064]\] available at <http://rssf.i2bc.paris-saclay.fr/toolbox/arnold/index.php>.

Supporting information {#sec022}
======================

###### Impact of *int* on SGI1 replication.

\(A\) Evolution of the percentage of *E*. *coli* KH95 cells bearing pVCR94^Green^ and SGI1^Red^ Δ*int* over 54 generations in the absence of antibiotics as monitored using FC. (B) Complementation of SGI1^Red^ Δ*int* with p*int*. KH95 carried pVCR94^GreenSp^ in these assays.

(TIF)

###### 

Click here for additional data file.

###### Impact of *traN*~*S*~ on SGI1 replication.

Evolution of the percentage of *E*. *coli* KH95 cells bearing SGI1^Red^ Δ*traN*~*S*~ and pVCR94^Green^ over 54 generations in the absence of antibiotics as monitored using FC.

(TIF)

###### 

Click here for additional data file.

###### Impact of *xis* on SGI1 replication.

\(A\) Evolution of the percentage of *E*. *coli* KH95 cells bearing pVCR94^Green^ and SGI1^Red^ Δ*xis* over 54 generations in the absence of antibiotics as monitored using FC. (B) Complementation of SGI1^Red^ Δ*xis* with p*xis*. KH95 carried pVCR94^GreenSp^ in these assays.

(TIF)

###### 

Click here for additional data file.

###### Impact of *rep* on SGI1 replication.

\(A\) Evolution of the percentage of *E*. *coli* KH95 cells bearing pVCR94^Green^ and SGI1^Red^ Δ*rep* over 54 generations in the absence of antibiotics as monitored using FC. (B) Complementation of SGI1^Red^ Δ*rep* with p*rep*. KH95 carried pVCR94^GreenSp^ in these assays.

(TIF)

###### 

Click here for additional data file.

###### Evolution of the percentage of *E*. *coli* KH95 cells bearing pSGI1 and pVCR94^GreenSp^ over 54 generations in the absence of antibiotics as monitored using FC.

(TIF)

###### 

Click here for additional data file.

###### *rep* expression is controlled by AcaCD.

\(A\) Sequence of the *rep'*-*'lacZ* translational fusion. The open reading frames are indicated by arrows. The predicted Shine-Dalgarno sequence of *rep* is underlined and its start codon is shown in bold. The red asterisk indicates the stop codon (in red) of *S004*. The sequence of *lacZ* is shown in blue whereas the sequence of SGI1 is shown in black. Predicted translation product are shown below the nucleotide sequence. (B) Schematic representation of the *rep'*-*'lacZ* translational fusion in SGI1. (C) β-galactosidase assays of the translational *rep*'-'*lacZ* fusion in SGI1^Kn^ performed in IncC-free cells (-), and in the presence of pVCR94^Sp^, its Δ*acaCD* mutant or p*acaCD* without or with arabinose (+ara).

(TIF)

###### 

Click here for additional data file.

###### Impact of *oriV* on SGI1 replication.

Evolution of the percentage of *E*. *coli* KH95 cells bearing pVCR94^Green^ and SGI1^Red^ Δ*oriV* over 54 generations in the absence of antibiotics as monitored using FC.

(TIF)

###### 

Click here for additional data file.

###### 

(DOCX)

###### 

Click here for additional data file.
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\* Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. \*

Dear Dr Burrus,

Thank you very much for submitting your Research Article entitled \'Replication of the Salmonella Genomic Island 1 (SGI1) triggered by helper IncC conjugative plasmids promotes incompatibility and plasmid loss\' to PLOS Genetics. Your manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some aspects of the manuscript that should be improved.

We therefore ask you to modify the manuscript according to the review recommendations before we can consider your manuscript for acceptance. Your revisions should address the specific points made by each reviewer.

In addition we ask that you:

1\) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2\) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our [archive](http://www.plosgenetics.org/article/browse/volume). If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to <plosgenetics@plos.org>.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our [Submission Checklist](http://journals.plos.org/plosgenetics/s/submit-now#loc-submission-checklist).

While revising your submission, please upload your figure files to the [Preflight Analysis and Conversion Engine](http://pace.apexcovantage.com/) (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>.

Please be aware that our [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability) requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as \"data not shown\" or \"unpublished results\" in manuscripts. All points should be backed up by data provided with the submission.

PLOS has incorporated [Similarity Check](http://www.crossref.org/crosscheck.html), powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and \'Revise Submission\' in the \'Submissions Needing Revision\' folder.

\[LINK\]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Diarmaid Hughes

Associate Editor

PLOS Genetics

Lotte Søgaard-Andersen

Section Editor: Prokaryotic Genetics

PLOS Genetics

Reviewer\'s Responses to Questions

**Comments to the Authors:**

**Please note here if the review is uploaded as an attachment.**

Reviewer \#1: Huguet and coworkers study the apparent incompatibilities between the Salmonella genomic island SIG1 and plasmids of the type IncC/IncA. They label SIG1 and plasmid with different inducible fluorescent reporter proteins to quantify presence of both elements in single cells by flow cytometry under different conditions and various mutant backgrounds. This was further backed up by qPCR and other DNA analyses, and finally by proposing similarities to related systems.

The main conclusion of the work is that SIG1 is replicating in its excised state, which is dependent on presence of an IncC-type plasmid with a transcription activator that controls expression of the SIG1 rep-gene. Yet, this replication causes an incompatibility, which leads to preferential loss of the plasmid.

COMMENTS

1\) I have very few criticisms on this work. It is very complete and clearly written. The results are convincing. There are clear differences in the expression levels of the fluorescence markers, which allows the authors to conclude that must correspond to three SIG1 states: a chromosomally integrated state (low fluo); an excised state (intermediate fluo) and a replicated excised state (high fluorescence). The plasmid leads to two fluorescent states: presence (high) or absence (low). This was benchmarked by qPCRs, by isolation of the physical SIG1 form, by different mutations that block the SIG1 from excision or from replicating.

The causal link of SIG1 replication after excision to induction of the Rep factor on SIG1 by the IncC plasmid AcaCD activator complex is very clearly demonstrated as well.

2\) The results of this work therefore clearly advance our understanding of integrated mobilizable elements that rely on other DNA replicons for their transfer. It is extremely curious that an element like SIG1 needs a plasmid for its excision and for its replication, and then hijacks the conjugative system of the plasmid by replacing part by its own conjugation proteins such that its own transfer is preferred over that by the plasmid. Parasites within parasites!

Apart from the molecular intricacies, the fate of SIG1-type elements is very relevant for spread of antimicrobial compound resistance factors, which are often encoded on them.

3\) Having said this: there must be some downsides to the SIG1-type strategy. What if there is cross-activation by a chromosomally integrated acaCD-type gene? Would that lead to loss of SIG1 or would it continue to replicate extra-chromosomally? Did the authors ever try such an experiment?

The flow cytometry data seem to suggest that there is some escape in the \'incompatibility\' conquest between excised replicating SIG1 and IncC. What happens in cells where IncC continues to be present? Are there any mutations inactivating SIG1 or is it simply a matter of chance?

4\) l. 120 Why are replication-deficient mutants not evolving spontaneously? You mention here and before that no wild-type strains have been found that carry SIG1 and an IncA/C plasmid.

5\) l. 142-144 maybe this is trivial, but how can you select for the presence of both elements that are incompatible in their replication? Will this not automatically lead to appearance of compensatory mutations somewhere?

6\) l. 230 Bit an awkward notation to write 8.38 x 10-5%. Maybe write both this and 81% in l. 231 as a proportion.

7\) l. 241/242: is there no interference at all by inducing all these different elements by arabinose?

8\) l. 472. Maybe not so uncertain. The big question seems to be what the actual molecular mechanism is that causes SIG1 replication to interfere with that of IncC. It seems to be a very gradual mechanism (i.e., taking more than 50 generations to lead to most of the reduction in a population), which might be due to the continued reliance of SIG1 on IncC? (If a cell would no longer have IncC, the AcaCD would no longer be expressed and SIG1 is out of business). What happens after SIG1 transfer? Is it lost from a \'donor\' cell?

9\) The figures included in the produced PDF are of embarrasing low quality. However, this happened to us recently as well (which was held against us), but we noticed that this is a mistake in the PLoS Genetics conversion process and should absolutely be brought to the attention of the editorial team and improved.

10\) Fig. 1. I noticed in this figure and in some others (e.g., Fig. 2C bottom right) that the FSC signal of the mChe-cells is sometimes lower than that of mNeon (panel C). In which growth phase are these cells measured? Do they have a slightly different cell size?

11\) Fig. 3D: why are these effects not tested in an ANOVA that takes all mutants and wild-type into consideration, rather than pair-wise t-tests? That would be better practice.

Reviewer \#2: This is a very interesting paper analysing the dynamics of two different types of MGEs, the Salmonella genomic island 1 (SGI1) and the IncC plasmids. Interestingly, while SGI1 requires IncC plasmids for mobility, these two elements are incompatible. This manuscript analyses the genetic causes of this incompatibility. Overall, this is a nice piece of work, and I just have some minor comments that hopefully will improve the manuscript:

\- In a very low percentage of cells, both elements may persist, suggesting they have mutated to avoid the incompatibility. It would be nice to sequence some of these stable elements. This could identify additional genes involved in the process.

\- Are the authors completely convinced that the SGI int mutant does not replicate in situ? Maybe this could be specifically tested, using the qPCR utilized in the study for the wt plasmid, for example.

\- Is Rep (together with its cognate oriV site) sufficient for autonomous SGI1 replication? Maybe the authors could clone these two elements in a suicide plasmid to test if they can support SGI1 replication.

\- I would like to see some discussion about the evolutionary advantage of this relationship, especially for the island? It is nice but strange that one parasitic element, the island, which requires the plasmid for transfer, can't cohabit with the helper plasmid.

Reviewer \#3: These authors present a careful and clever analysis of co-existence of conjugative plasmids and ICE-like elements in Salmonella. Overall, I thought the paper makes a nice contribution to the field and is well written (albeit maybe a little wordy), with nice illustrations and figure design. I have no major problems with the ms as presented here, and my comments refer to potential follow up studies that might give a little more impact to this paper. They are as follows:

1\) In the primary experiment shown in Fig. 2, the authors were able to select out rare clones (undetectable by flow cytometry) where both elements were still co-resident\-- it would be interesting to plate these on antibiotic plates, select some colonies (maybe 10 or so) and repeat the passage in the absence of selection to see if they get the same result\-- it is possible that there could have been selections for suppressor mutants of the replication/incompatibility functions encoded by the wild type elements and these might further inform the mechanisms.

2\) The authors might have published this previously, but it would be interesting t know whether there is a basal level of transfer (eg. solid surface matings) of the Island in the absence of a helper plasmid..

Otherwise I thought this was a nice paper.

\*\*\*\*\*\*\*\*\*\*

**Have all data underlying the figures and results presented in the manuscript been provided?**

Large-scale datasets should be made available via a public repository as described in the *PLOS Genetics* [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability), and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosgenetics/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

Reviewer \#3: No

10.1371/journal.pgen.1008965.r002
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Click here for additional data file.
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Dear Dr Burrus,

We are pleased to inform you that your manuscript entitled \"Replication of the Salmonella Genomic Island 1 (SGI1) triggered by helper IncC conjugative plasmids promotes incompatibility and plasmid loss\" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional accept, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you've already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at <plosgenetics@plos.org>.

In the meantime, please log into Editorial Manager at <https://www.editorialmanager.com/pgenetics/>, click the \"Update My Information\" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to 'Update my Information' (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about one way to make your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Diarmaid Hughes

Associate Editor

PLOS Genetics

Lotte Søgaard-Andersen

Section Editor: Prokaryotic Genetics

PLOS Genetics

[www.plosgenetics.org](http://www.plosgenetics.org)

Twitter: \@PLOSGenetics

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

Comments from the reviewers (if applicable):

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Data Deposition**

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the [Dryad Digital Repository](http://www.datadryad.org). As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our [website](http://journals.plos.org/plosgenetics/s/data-availability#loc-recommended-repositories).

The following link will take you to the Dryad record for your article, so you won\'t have to re‐enter its bibliographic information, and can upload your files directly: 

<http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-20-00839R1>

More information about depositing data in Dryad is available at <http://www.datadryad.org/depositing>. If you experience any difficulties in submitting your data, please contact <help@datadryad.org> for support.

Additionally, please be aware that our [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability) requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Press Queries**

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper\'s publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there\'s anything the journal should know or you\'d like more information, please get in touch via <plosgenetics@plos.org>.

10.1371/journal.pgen.1008965.r004
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Replication of the Salmonella Genomic Island 1 (SGI1) triggered by helper IncC conjugative plasmids promotes incompatibility and plasmid loss

Dear Dr Burrus,

We are pleased to inform you that your manuscript entitled \"Replication of the Salmonella Genomic Island 1 (SGI1) triggered by helper IncC conjugative plasmids promotes incompatibility and plasmid loss\" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Jason Norris

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN \| United Kingdom

<plosgenetics@plos.org> \| +44 (0) 1223-442823

[plosgenetics.org](http://plosgenetics.org) \| Twitter: \@PLOSGenetics

[^1]: The authors have declared that no competing interests exist.
